 | • レポートコード：GIR-107A14856 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、経口造影剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口造影剤の種類別市場規模（バリウムベース造影剤、ヨウ素化造影剤、ガドリニウムベース造影剤、マイクロバブル造影剤）、用途別市場規模（心血管障害、がん、胃腸障害、筋骨格系障害、神経障害、腎障害）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・経口造影剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GE Healthcare (US)、Bracco Imaging (Italy)、Bayer HealthCare (Germany)、Guerbet (France)、Lantheus (US)、Daiichi Sankyo (Japan)、Unijules Life Sciences (India)、J.B. Chemicals and Pharmaceuticals (India)、Spago Nanomedicine (Sweden)、Taejoon Pharm (South Korea)、Jodas (India)、Magnus Health (India) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：バリウムベース造影剤、ヨウ素化造影剤、ガドリニウムベース造影剤、マイクロバブル造影剤 ・用途別分析2016年-2026年：心血管障害、がん、胃腸障害、筋骨格系障害、神経障害、腎障害 ・経口造影剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経口造影剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経口造影剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経口造影剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経口造影剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oral Contrast Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oral Contrast Agent size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Oral Contrast Agent market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oral Contrast Agent market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Market segment by Application can be divided into
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
The key market players for global Oral Contrast Agent market are listed below:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Oral Contrast Agent product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Contrast Agent, with price, sales, revenue and global market share of Oral Contrast Agent from 2019 to 2021.
Chapter 3, the Oral Contrast Agent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Contrast Agent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oral Contrast Agent market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Oral Contrast Agent sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Oral Contrast Agent Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Contrast Agent Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Barium-based Contrast Media
1.2.3 Iodinated Contrast Media
1.2.4 Gadolinium-based Contrast Media
1.2.5 Microbubble Contrast Media
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Contrast Agent Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cardiovascular Disorders
1.3.3 Cancer
1.3.4 Gastrointestinal Disorders
1.3.5 Musculoskeletal Disorders
1.3.6 Neurological Disorders
1.3.7 Nephrological Disorders
1.4 Global Oral Contrast Agent Market Size & Forecast
1.4.1 Global Oral Contrast Agent Sales in Value (2016-2026))
1.4.2 Global Oral Contrast Agent Sales in Volume (2016-2026)
1.4.3 Global Oral Contrast Agent Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Oral Contrast Agent Production Capacity Analysis
1.5.1 Global Oral Contrast Agent Total Production Capacity (2016-2026)
1.5.2 Global Oral Contrast Agent Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Contrast Agent Market Drivers
1.6.2 Oral Contrast Agent Market Restraints
1.6.3 Oral Contrast Agent Trends Analysis
2 Manufacturers Profiles
2.1 GE Healthcare (US)
2.1.1 GE Healthcare (US) Details
2.1.2 GE Healthcare (US) Major Business
2.1.3 GE Healthcare (US) Oral Contrast Agent Product and Services
2.1.4 GE Healthcare (US) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bracco Imaging (Italy)
2.2.1 Bracco Imaging (Italy) Details
2.2.2 Bracco Imaging (Italy) Major Business
2.2.3 Bracco Imaging (Italy) Oral Contrast Agent Product and Services
2.2.4 Bracco Imaging (Italy) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer HealthCare (Germany)
2.3.1 Bayer HealthCare (Germany) Details
2.3.2 Bayer HealthCare (Germany) Major Business
2.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Product and Services
2.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Guerbet (France)
2.4.1 Guerbet (France) Details
2.4.2 Guerbet (France) Major Business
2.4.3 Guerbet (France) Oral Contrast Agent Product and Services
2.4.4 Guerbet (France) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Lantheus (US)
2.5.1 Lantheus (US) Details
2.5.2 Lantheus (US) Major Business
2.5.3 Lantheus (US) Oral Contrast Agent Product and Services
2.5.4 Lantheus (US) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Daiichi Sankyo (Japan)
2.6.1 Daiichi Sankyo (Japan) Details
2.6.2 Daiichi Sankyo (Japan) Major Business
2.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Product and Services
2.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Unijules Life Sciences (India)
2.7.1 Unijules Life Sciences (India) Details
2.7.2 Unijules Life Sciences (India) Major Business
2.7.3 Unijules Life Sciences (India) Oral Contrast Agent Product and Services
2.7.4 Unijules Life Sciences (India) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 J.B. Chemicals and Pharmaceuticals (India)
2.8.1 J.B. Chemicals and Pharmaceuticals (India) Details
2.8.2 J.B. Chemicals and Pharmaceuticals (India) Major Business
2.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product and Services
2.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Spago Nanomedicine (Sweden)
2.9.1 Spago Nanomedicine (Sweden) Details
2.9.2 Spago Nanomedicine (Sweden) Major Business
2.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Product and Services
2.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Taejoon Pharm (South Korea)
2.10.1 Taejoon Pharm (South Korea) Details
2.10.2 Taejoon Pharm (South Korea) Major Business
2.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Product and Services
2.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Jodas (India)
2.11.1 Jodas (India) Details
2.11.2 Jodas (India) Major Business
2.11.3 Jodas (India) Oral Contrast Agent Product and Services
2.11.4 Jodas (India) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Magnus Health (India)
2.12.1 Magnus Health (India) Details
2.12.2 Magnus Health (India) Major Business
2.12.3 Magnus Health (India) Oral Contrast Agent Product and Services
2.12.4 Magnus Health (India) Oral Contrast Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Oral Contrast Agent Sales by Manufacturer
3.1 Global Oral Contrast Agent Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oral Contrast Agent Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oral Contrast Agent
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Contrast Agent Manufacturer Market Share
3.4.2 Top 6 Oral Contrast Agent Manufacturer Market Share
3.5 Global Oral Contrast Agent Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oral Contrast Agent Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Contrast Agent Market Size by Region
4.1.1 Global Oral Contrast Agent Sales in Volume by Region (2016-2026)
4.1.2 Global Oral Contrast Agent Revenue by Region (2016-2026)
4.2 North America Oral Contrast Agent Revenue (2016-2026)
4.3 Europe Oral Contrast Agent Revenue (2016-2026)
4.4 Asia-Pacific Oral Contrast Agent Revenue (2016-2026)
4.5 South America Oral Contrast Agent Revenue (2016-2026)
4.6 Middle East and Africa Oral Contrast Agent Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oral Contrast Agent Sales in Volume by Type (2016-2026)
5.2 Global Oral Contrast Agent Revenue by Type (2016-2026)
5.3 Global Oral Contrast Agent Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oral Contrast Agent Sales in Volume by Application (2016-2026)
6.2 Global Oral Contrast Agent Revenue by Application (2016-2026)
6.3 Global Oral Contrast Agent Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oral Contrast Agent Sales by Type (2016-2026)
7.2 North America Oral Contrast Agent Sales by Application (2016-2026)
7.3 North America Oral Contrast Agent Market Size by Country
7.3.1 North America Oral Contrast Agent Sales in Volume by Country (2016-2026)
7.3.2 North America Oral Contrast Agent Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Contrast Agent Sales by Type (2016-2026)
8.2 Europe Oral Contrast Agent Sales by Application (2016-2026)
8.3 Europe Oral Contrast Agent Market Size by Country
8.3.1 Europe Oral Contrast Agent Sales in Volume by Country (2016-2026)
8.3.2 Europe Oral Contrast Agent Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oral Contrast Agent Sales by Type (2016-2026)
9.2 Asia-Pacific Oral Contrast Agent Sales by Application (2016-2026)
9.3 Asia-Pacific Oral Contrast Agent Market Size by Region
9.3.1 Asia-Pacific Oral Contrast Agent Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oral Contrast Agent Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oral Contrast Agent Sales by Type (2016-2026)
10.2 South America Oral Contrast Agent Sales by Application (2016-2026)
10.3 South America Oral Contrast Agent Market Size by Country
10.3.1 South America Oral Contrast Agent Sales in Volume by Country (2016-2026)
10.3.2 South America Oral Contrast Agent Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Contrast Agent Sales by Type (2016-2026)
11.2 Middle East & Africa Oral Contrast Agent Sales by Application (2016-2026)
11.3 Middle East & Africa Oral Contrast Agent Market Size by Country
11.3.1 Middle East & Africa Oral Contrast Agent Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oral Contrast Agent Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oral Contrast Agent Typical Distributors
12.3 Oral Contrast Agent Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oral Contrast Agent Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oral Contrast Agent Revenue by Application, (USD Million), 2021-2026
Table 3. GE Healthcare (US) Basic Information, Manufacturing Base and Competitors
Table 4. GE Healthcare (US) Major Business
Table 5. GE Healthcare (US) Oral Contrast Agent Product and Services
Table 6. GE Healthcare (US) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bracco Imaging (Italy) Basic Information, Manufacturing Base and Competitors
Table 8. Bracco Imaging (Italy) Major Business
Table 9. Bracco Imaging (Italy) Oral Contrast Agent Product and Services
Table 10. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer HealthCare (Germany) Basic Information, Manufacturing Base and Competitors
Table 12. Bayer HealthCare (Germany) Major Business
Table 13. Bayer HealthCare (Germany) Oral Contrast Agent Product and Services
Table 14. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Guerbet (France) Basic Information, Manufacturing Base and Competitors
Table 16. Guerbet (France) Major Business
Table 17. Guerbet (France) Oral Contrast Agent Product and Services
Table 18. Guerbet (France) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Lantheus (US) Basic Information, Manufacturing Base and Competitors
Table 20. Lantheus (US) Major Business
Table 21. Lantheus (US) Oral Contrast Agent Product and Services
Table 22. Lantheus (US) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Daiichi Sankyo (Japan) Basic Information, Manufacturing Base and Competitors
Table 24. Daiichi Sankyo (Japan) Major Business
Table 25. Daiichi Sankyo (Japan) Oral Contrast Agent Product and Services
Table 26. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Unijules Life Sciences (India) Basic Information, Manufacturing Base and Competitors
Table 28. Unijules Life Sciences (India) Major Business
Table 29. Unijules Life Sciences (India) Oral Contrast Agent Product and Services
Table 30. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. J.B. Chemicals and Pharmaceuticals (India) Basic Information, Manufacturing Base and Competitors
Table 32. J.B. Chemicals and Pharmaceuticals (India) Major Business
Table 33. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product and Services
Table 34. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Spago Nanomedicine (Sweden) Basic Information, Manufacturing Base and Competitors
Table 36. Spago Nanomedicine (Sweden) Major Business
Table 37. Spago Nanomedicine (Sweden) Oral Contrast Agent Product and Services
Table 38. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Taejoon Pharm (South Korea) Basic Information, Manufacturing Base and Competitors
Table 40. Taejoon Pharm (South Korea) Major Business
Table 41. Taejoon Pharm (South Korea) Oral Contrast Agent Product and Services
Table 42. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Jodas (India) Basic Information, Manufacturing Base and Competitors
Table 44. Jodas (India) Major Business
Table 45. Jodas (India) Oral Contrast Agent Product and Services
Table 46. Jodas (India) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Magnus Health (India) Basic Information, Manufacturing Base and Competitors
Table 48. Magnus Health (India) Major Business
Table 49. Magnus Health (India) Oral Contrast Agent Product and Services
Table 50. Magnus Health (India) Oral Contrast Agent Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Oral Contrast Agent Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 52. Global Oral Contrast Agent Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Oral Contrast Agent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Oral Contrast Agent Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 55. Head Office and Oral Contrast Agent Production Site of Key Manufacturer
Table 56. Oral Contrast Agent New Entrant and Capacity Expansion Plans
Table 57. Oral Contrast Agent Mergers & Acquisitions in the Past Five Years
Table 58. Global Oral Contrast Agent Sales by Region (2016-2021e) & (K Pcs)
Table 59. Global Oral Contrast Agent Sales by Region (2021-2026) & (K Pcs)
Table 60. Global Oral Contrast Agent Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Oral Contrast Agent Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Oral Contrast Agent Sales by Type (2016-2021e) & (K Pcs)
Table 63. Global Oral Contrast Agent Sales by Type (2021-2026) & (K Pcs)
Table 64. Global Oral Contrast Agent Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Oral Contrast Agent Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Oral Contrast Agent Price by Type (2016-2021e) & (USD/Pcs)
Table 67. Global Oral Contrast Agent Price by Type (2021-2026) & (USD/Pcs)
Table 68. Global Oral Contrast Agent Sales by Application (2016-2021e) & (K Pcs)
Table 69. Global Oral Contrast Agent Sales by Application (2021-2026) & (K Pcs)
Table 70. Global Oral Contrast Agent Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Oral Contrast Agent Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Oral Contrast Agent Price by Application (2016-2021e) & (USD/Pcs)
Table 73. Global Oral Contrast Agent Price by Application (2021-2026) & (USD/Pcs)
Table 74. North America Oral Contrast Agent Sales by Country (2016-2021e) & (K Pcs)
Table 75. North America Oral Contrast Agent Sales by Country (2021-2026) & (K Pcs)
Table 76. North America Oral Contrast Agent Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Oral Contrast Agent Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Oral Contrast Agent Sales by Type (2016-2021e) & (K Pcs)
Table 79. North America Oral Contrast Agent Sales by Type (2021-2026) & (K Pcs)
Table 80. North America Oral Contrast Agent Sales by Application (2016-2021e) & (K Pcs)
Table 81. North America Oral Contrast Agent Sales by Application (2021-2026) & (K Pcs)
Table 82. Europe Oral Contrast Agent Sales by Country (2016-2021e) & (K Pcs)
Table 83. Europe Oral Contrast Agent Sales by Country (2021-2026) & (K Pcs)
Table 84. Europe Oral Contrast Agent Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Oral Contrast Agent Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Oral Contrast Agent Sales by Type (2016-2021e) & (K Pcs)
Table 87. Europe Oral Contrast Agent Sales by Type (2021-2026) & (K Pcs)
Table 88. Europe Oral Contrast Agent Sales by Application (2016-2021e) & (K Pcs)
Table 89. Europe Oral Contrast Agent Sales by Application (2021-2026) & (K Pcs)
Table 90. Asia-Pacific Oral Contrast Agent Sales by Region (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Oral Contrast Agent Sales by Region (2021-2026) & (K Pcs)
Table 92. Asia-Pacific Oral Contrast Agent Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Oral Contrast Agent Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Oral Contrast Agent Sales by Type (2016-2021e) & (K Pcs)
Table 95. Asia-Pacific Oral Contrast Agent Sales by Type (2021-2026) & (K Pcs)
Table 96. Asia-Pacific Oral Contrast Agent Sales by Application (2016-2021e) & (K Pcs)
Table 97. Asia-Pacific Oral Contrast Agent Sales by Application (2021-2026) & (K Pcs)
Table 98. South America Oral Contrast Agent Sales by Country (2016-2021e) & (K Pcs)
Table 99. South America Oral Contrast Agent Sales by Country (2021-2026) & (K Pcs)
Table 100. South America Oral Contrast Agent Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Oral Contrast Agent Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Oral Contrast Agent Sales by Type (2016-2021e) & (K Pcs)
Table 103. South America Oral Contrast Agent Sales by Type (2021-2026) & (K Pcs)
Table 104. South America Oral Contrast Agent Sales by Application (2016-2021e) & (K Pcs)
Table 105. South America Oral Contrast Agent Sales by Application (2021-2026) & (K Pcs)
Table 106. Middle East & Africa Oral Contrast Agent Sales by Country (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Oral Contrast Agent Sales by Country (2021-2026) & (K Pcs)
Table 108. Middle East & Africa Oral Contrast Agent Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Oral Contrast Agent Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Oral Contrast Agent Sales by Type (2016-2021e) & (K Pcs)
Table 111. Middle East & Africa Oral Contrast Agent Sales by Type (2021-2026) & (K Pcs)
Table 112. Middle East & Africa Oral Contrast Agent Sales by Application (2016-2021e) & (K Pcs)
Table 113. Middle East & Africa Oral Contrast Agent Sales by Application (2021-2026) & (K Pcs)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Oral Contrast Agent Typical Distributors
Table 117. Oral Contrast Agent Typical Customers
List of Figures
Figure 1. Oral Contrast Agent Picture
Figure 2. Global Oral Contrast Agent Sales Market Share by Type in 2020
Figure 3. Barium-based Contrast Media
Figure 4. Iodinated Contrast Media
Figure 5. Gadolinium-based Contrast Media
Figure 6. Microbubble Contrast Media
Figure 7. Global Oral Contrast Agent Sales Market Share by Application in 2020
Figure 8. Cardiovascular Disorders
Figure 9. Cancer
Figure 10. Gastrointestinal Disorders
Figure 11. Musculoskeletal Disorders
Figure 12. Neurological Disorders
Figure 13. Nephrological Disorders
Figure 14. Global Oral Contrast Agent Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Oral Contrast Agent Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Oral Contrast Agent Sales (2016-2026) & (K Pcs)
Figure 17. Global Oral Contrast Agent Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Oral Contrast Agent Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Oral Contrast Agent Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Oral Contrast Agent Market Drivers
Figure 21. Oral Contrast Agent Market Restraints
Figure 22. Oral Contrast Agent Market Trends
Figure 23. Global Oral Contrast Agent Sales Market Share by Manufacturer in 2020
Figure 24. Global Oral Contrast Agent Revenue Market Share by Manufacturer in 2020
Figure 25. Oral Contrast Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Oral Contrast Agent Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Oral Contrast Agent Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Oral Contrast Agent Sales Market Share by Region (2016-2026)
Figure 29. Global Oral Contrast Agent Revenue Market Share by Region (2016-2026)
Figure 30. North America Oral Contrast Agent Revenue (2016-2026) & (USD Million)
Figure 31. Europe Oral Contrast Agent Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Oral Contrast Agent Revenue (2016-2026) & (USD Million)
Figure 33. South America Oral Contrast Agent Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Oral Contrast Agent Revenue (2016-2026) & (USD Million)
Figure 35. Global Oral Contrast Agent Sales Market Share by Type (2016-2026)
Figure 36. Global Oral Contrast Agent Revenue Market Share by Type (2016-2026)
Figure 37. Global Oral Contrast Agent Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Oral Contrast Agent Sales Market Share by Application (2016-2026)
Figure 39. Global Oral Contrast Agent Revenue Market Share by Application (2016-2026)
Figure 40. Global Oral Contrast Agent Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Oral Contrast Agent Sales Market Share by Type (2016-2026)
Figure 42. North America Oral Contrast Agent Sales Market Share by Application (2016-2026)
Figure 43. North America Oral Contrast Agent Sales Market Share by Country (2016-2026)
Figure 44. North America Oral Contrast Agent Revenue Market Share by Country (2016-2026)
Figure 45. United States Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Oral Contrast Agent Sales Market Share by Type (2016-2026)
Figure 49. Europe Oral Contrast Agent Sales Market Share by Application (2016-2026)
Figure 50. Europe Oral Contrast Agent Sales Market Share by Country (2016-2026)
Figure 51. Europe Oral Contrast Agent Revenue Market Share by Country (2016-2026)
Figure 52. Germany Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Oral Contrast Agent Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Oral Contrast Agent Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Oral Contrast Agent Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Oral Contrast Agent Revenue Market Share by Region (2016-2026)
Figure 61. China Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Oral Contrast Agent Sales Market Share by Type (2016-2026)
Figure 68. South America Oral Contrast Agent Sales Market Share by Application (2016-2026)
Figure 69. South America Oral Contrast Agent Sales Market Share by Country (2016-2026)
Figure 70. South America Oral Contrast Agent Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Oral Contrast Agent Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Oral Contrast Agent Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Oral Contrast Agent Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Oral Contrast Agent Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Oral Contrast Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界のヨウ素化造影剤（ICM）市場 2021：企業別、地域別、種類・用途別 The Iodinated Contrast Media (ICM) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界の造影剤注入装置市場 2021：企業別、地域別、種類・用途別 The Contrast Media Injector market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の造影剤注入ライン市場 2021：企業別、地域別、種類・用途別 The Contrast Injection Lines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- CTコントラストインジェクター市場：世界及び中国市場分析・予測（～2024年） CT Contrast Injector Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global CT Contrast Injector industry with a focus on the Chinese market. The report provides key statistics on the market status of the CT Contrast Injector manufac…
- 高圧CTコントラストインジェクター市場：世界及び中国市場分析・予測（～2024年） High Pressure CT Contrast Injector Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global High Pressure CT Contrast Injector industry with a focus on the Chinese market. The report provides key statistics on the market status of the …